CardioVerse: The cardiovascular medicine in the era of Metaverse.

Détails

Ressource 1Télécharger: 35568263.pdf (1052.83 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_F4D806405BF9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
CardioVerse: The cardiovascular medicine in the era of Metaverse.
Périodique
Trends in cardiovascular medicine
Auteur⸱e⸱s
Skalidis I., Muller O., Fournier S.
ISSN
1873-2615 (Electronic)
ISSN-L
1050-1738
Statut éditorial
Publié
Date de publication
11/2023
Peer-reviewed
Oui
Volume
33
Numéro
8
Pages
471-476
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
The recent pandemic launched an acceleration in adopting telemedicine by cardiovascular health and triggered the flourishing of technological advancements, such as the metaverse, which is a novel interactive mix of digital worlds that leverages augmented reality with virtual reality. The CardioVerse represents a theoretical term for the embracement of the metaverse by cardiovascular medicine, encompassing the endless possibilities as well as the challenges that it holds and introduces new dimensions to disease education, prevention and diagnosis. Its applications are numerous, notably in enhancing medical visits, assisting cardiovascular interventions and reshaping the way medical education is provided. Although obstacles are expected in diverse domains such as security, technical, legislative and regulatory, the utilization of non-fungible tokens as a security asset for patient data appears as potential solution.
Mots-clé
Humans, Cardiovascular Agents, Augmented Reality, Education, Medical, Pandemics, Telemedicine, Augmented reality, Education, Metaverse, Non-fungible tokens, Virtual reality
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/05/2022 8:06
Dernière modification de la notice
09/02/2024 9:55
Données d'usage